Ecto-ATPases and receptors for ATP

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 60, Issue 3, 1997, Pages 81-82

  Ziganshin, A U ^a   Ziganshina, L E ^a   Burnstock, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; CALCIUM; DIVALENT CATION; MAGNESIUM; PURINE P2 RECEPTOR;

ANIMAL; BINDING COMPETITION; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EXTRACELLULAR MATRIX; METABOLISM; OOCYTE; PHYSIOLOGY; REVIEW; SMOOTH MUSCLE; XENOPUS LAEVIS;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANIMALS; BINDING, COMPETITIVE; CALCIUM; CATIONS, DIVALENT; CELLS, CULTURED; EXTRACELLULAR MATRIX; MAGNESIUM; MUSCLE, SMOOTH; OOCYTES; RECEPTORS, PURINERGIC P2; XENOPUS LAEVIS;

EID: 0031135404     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. M. P. Abbracchio and G. Burnstock, Pharmacol. Ther., 64, 445-475 (1994).
2. A. Agarwal, O. P. Shukla, and B. L. Tekwani, Int. J. Biochem., 24, 1447-1452 (1992).
3. R. K. Banerjee, Mol. Cell. Biochem., 37, 91-99 (1981).
4. M. W. Beukers, I. M. Pirovano, A.van Weert, et al., Biochem. Pharmacol., 46, 1959-1966 (1993).
5. P. D. Boyer, Biochim. Biophys. Acta, 1140, 215-250 (1993).
6. G. Burnstock and C. Kennedy, Gen. Pharmacol, 16, 433-440 (1985).
7. G. Burnstock, Drug Dev. Res., 28, 195-206 (1993).
8. O. Culic, Q. H. Huang, D. Flanagan, et al., Biochem. J., 285, 47-53 (1992).
9. N. J. Cusack, Drug Dev. Res., 28, 244-252 (1993).
10. N. S. Dhalla and D. Zhao, Prog. Biophys. Molec. Biol., 52, 1-37 (1988).
11. K. E. Dombrowski, J. M. Trevillyan, C. Cone, et al., Biochemistry, 32, 6515-6522 (1993).
12. G. R. Dubyak and C. El-Moatassim, Am. J. Physiol., 265, C577-C606 (1993).
13. E. Garcia-Martin, S. Gonzales-Cabanillas, and C. Gutierrez-Merino, J. Neurochem., 55, 370-378 (1990).
14. J. C. Gilbert, J. M. Allen, B. G. Townsend, M. G. Wylie, J. Neuropharmacol, 17, 419-421 (1978).
15. J. L. Gordon, Biochem. J., 233, 309-319 (1986).
16. E. J. Grondai and H. Zimmermann, J. Neurpchem., 147, 871-881 (1986).
17. A. Guilherme, J. R. Meyer-Fernandes, and A. Vieyra, Biochemistry, 30, 5700-5706 (1991).
18. C. H. V. Hoyle, Autonomic Neuroeffector Mechanisms, G. Burnstock, C. H. V. Hoyle (eds.), Harwood Academic Publishers, Chur (1992), pp. 367-407.
19. B. Juul, M. E. Luscher, C. Aalkjaer, L. Plesner, Biochim. Biophys. Acta., 1067, 201-207 (1991).
20. A. F. Knowles, Arch. Biochem. Biophys., 263, 264-271 (1988).
21. N. Kurebayashi and Y. Ogawa, J. Muscle. Res. Cell Montil., 12, 355-365 (1991).
22. S. H. Lin, O. Culic, D. Flanagan, D. C. Hixson, Biochem. J., 278, 155-161 (1991).
23. G. C. Majumder and R. Biswass, Biochem. J., 183, 737-743 (1979).
24. R. N. Margolis, M. J. Schell, S. I. Taylor, A. L. Hubbard, Biochem Biophys. Res. Commun., 166, 562-566, (1990).
25. P. Meghji, Drug Dev. Res., 28, 214-219 (1993).
26. F. D. Moodie, H. Baum, P. J. Butterworth, T. J. Peters, Eur. J. Biochem., 202, 1209-1215 (1991).
27. A. K. Nagy, T. A. Shuster, M. D. Rosenberg, J. Neurochem., 40, 226-234 (1983).
28. S. M. Najjar, D. Accili, N. Philippe, et al., J. Biol. Chem., 268, 1201-1206 (1993).
29. L. C. Nuttle, C. El-Moatassim, G. R. Dubyak, Mol. Pharmacol., 44, 93-101 (1993).
30. T. Paramarcaki, O. Isolas, Mol. Cell. Biochem., 97, 1-8 (1990).
31. J. D. Pearson, Methods Used in Adenosine Research, D. M. Paton (ed.), Plenum Press, New York (1985), pp. 83-107.
32. J. D. Pearson, E. L. Gordon, and L. L. Slakey, Role of Adenosine and Adenine Nucleotides in the Biological System, S. Imai, M. Nakazawa (eds.), Isevier Science Publishers, Amsterdam (1991), pp. 313-320.
33. M. Picher, Y. P. Cote, R. Beliveau, et al., J. Biol. Chem., 268, 4699-4703 (1993).
34. J. J. Sarkis and C. Salto, Brain Res. Bull., 26, 871-876 (1991).
35. G. B. Segel, D. H. Ryan, M. A. Lichtman, J. Cell. Physiol., 124, 424-432 (1985).
36. E. Sigel, J. Membrane. Biol., 117, 201-221 (1990).
37. J. C. Skou and M. Esmann, J. Bioenerg. Biomembr., 24, 249-261 (1992).
38. M. Suzuki, K. Muraki, Y. Imaizumi, M. Watanabe, Brit. J. Pharmacol, 107, 134-140 (1992).
39. R. S. Tuan and N. Bigioni, Development, 110, 505-513 (1990).
40. Y. Uyama, Y. Imaizumi, abd M. Watanabe, Br. J. Pharmacol., 110, 565-572 (1993).
41. T. E. Webb, J. Simon, B. J. Krishek, et al., FEBS Lett., 324, 219-225 (1993).
42. R. L. Wortmann, L. M. Ryan, B. Karas, D. J. McCarthy, Adv. Exp. Med. Biol., 195, Pt A, 153-156 (1986).
43. F. Wuytack and L. Raeymaekers, J. Bioenerg. Biomembr., 24, 285-300 (1992).
44. D. Zhao, N. S. Dhalla, Can. J. Physiol. Pharmacol., 67, 546-552 (1989).
45. A. U. Ziganshin, C. H. V. Hoyle, X. Bo, et al., Brit. J. Pharmacol., 110, 1491-1495 (1993).
46. A. U. Ziganshin, C. H. V. Hoyle, G. Burnstock, Drug Dev. Res., 32, 134-146 (1994).
47. A. U. Ziganshin, C. H. V. Hoyle, G. Lambrecht, et al., Brit. J. Pharmacol., 111, 923-929 (1994).
48. A. U. Ziganshin, C. H. V. Hoyle, L. E. Ziganshina, G. Burnstock, Brit. J. Pharmacol., 113, 669-674 (1994).
49. A. U. Ziganshin, L. E. Ziganshina, B. F. King, G. Burnstock, J. Physiol (London), 480P, 60P (1994).
50. A. U. Ziganshin, 5th Wellcome Trust Annual Meeting of Overseas Fellows, London (1995), p. 69.
51. A. U. Ziganshin, E. A. Berdnikov, L. E. Ziganshina, et al., Gen. Pharmacol., 26, 527-532 (1995).
52. A. U. Ziganshin, L. E. Ziganshina, P. Bodin, et al., Biochem. Mol. Biol. Int., 36, 863-869 (1995).
53. A. U. Ziganshin, L. E. Ziganshina, C. H. V. Hoyle, G. Burnstock, Brit. J. Pharmacol., 114, 632-639 (1995).
54. A. U. Ziganshin, L. E. Ziganshina, B. F. King, G. Burnstock, Pflugers Arch., 429, 412-418 (1995).
55. A. U. Ziganshin, L. E. Ziganshina, B. F. King, et al., Pharmacol. Res., 31, P. 201 (1995).
56. A. U. Ziganshin, L. E. Ziganshina, B. F. King, et al., Mol. Pharmacol., (1996), In press.